TOMM40, translocase of outer mitochondrial membrane 40, 10452
N. diseases: 113; N. variants: 34
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 19 | 44900155 | intron variant | C/T | snv | 0.52 |
|
0.800 | 1.000 | 3 | 2013 | 2019 | ||||||||
|
1.000 | 0.080 | 19 | 44900155 | intron variant | C/T | snv | 0.52 |
|
Nervous System Diseases; Mental Disorders | 0.800 | 1.000 | 2 | 2013 | 2019 | |||||||
|
1.000 | 0.080 | 19 | 44900155 | intron variant | C/T | snv | 0.52 |
|
0.800 | 1.000 | 2 | 2013 | 2019 | ||||||||
|
1.000 | 0.080 | 19 | 44900155 | intron variant | C/T | snv | 0.52 |
|
0.800 | 1.000 | 2 | 2012 | 2019 | ||||||||
|
1.000 | 0.080 | 19 | 44900155 | intron variant | C/T | snv | 0.52 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 19 | 44900155 | intron variant | C/T | snv | 0.52 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 19 | 44895376 | intron variant | G/C | snv | 0.12 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 19 | 44895376 | intron variant | G/C | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.080 | 19 | 44890259 | intron variant | C/T | snv | 7.3E-03 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 19 | 44902242 | 3 prime UTR variant | G/A | snv | 1.7E-02 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 2 | 2018 | 2019 | |||||||
|
1.000 | 0.080 | 19 | 44900801 | missense variant | C/T | snv | 4.9E-04 | 5.7E-04 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
Nervous System Diseases; Mental Disorders | 0.810 | 1.000 | 14 | 2009 | 2019 | |||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.800 | 1.000 | 3 | 2009 | 2012 | ||||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.700 | 1.000 | 3 | 2009 | 2012 | ||||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.800 | 1.000 | 2 | 2012 | 2019 | ||||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
Respiratory Tract Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.800 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.882 | 0.160 | 19 | 44892009 | intron variant | G/A | snv | 0.69 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |